参考文献/References:
［1］ PAHL J，CERWENKA A.Tricking the balance：NK cells in anti-cancer immunity［J］.Immunobiology，2017，222（1）：11-20.
［2］ WALDMANN T A.JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma：Inspired by functional and structural genomics［J］.Mol Cell Endocrinol，2017，451：66-70.
［3］ LIANG S，WEI H，SUN R，et al.IFNalpha regulates NK cell cytotoxicity through STAT1 pathway［J］.Cytokine，2003，23（6）：190-199.
［4］ WANG K S，FRANK D A，RITZ J.Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4［J］.Blood，2000，95（10）：3183-3190.
［5］ ECKELHART E，WARSCH W，ZEBEDIN E，et al.A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development［J］.Blood，2011，117（5）：1565-1573.
［6］ IMADA K，BLOOM E T，NAKAJIMA H，et al.Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity［J］.J Exp Med，1998，188（11）：2067-2074.
［7］ KORTYLEWSKI M，YU H.Role of Stat3 in suppressing anti-tumor immunity［J］.Curr Opin Immunol，2008，20（2）：228-233.
［8］ SPITS H，BERNINK J H，LANIER L.NK cells and type 1 innate lymphoid cells：partners in host defense［J］.Nat Immunol，2016，17（7）：758-764.
［9］ FREUD A G，YU J，CALIGIURI M A.Human natural killer cell development in secondary lymphoid tissues［J］.Semin Immunol，2014，26（2）：132-137.
［10］ MELSEN J E，LUGTHART G，LANKESTER A C，et al.Human circulating and tissue-resident CD56bright natural killer cell populations［J］.Front Immunol，2016，7：262.
［11］ LOPEZ-BOTET M，VILCHES C，REDONDO-PACHON D，et al.Dual role of natural killer cells on graft rejection and control of cytomegalovirus infection in renal transplantation［J］.Front Immunol，2017，8：166.
［12］ ZHANG C，TIAN Z.NK cell subsets in autoimmune diseases［J］.J Autoimmun，2017，83：22-30.
［13］ RAJALINGAM R.The impact of HLA class I-specific killer cell immunoglobulin-like receptors on antibody-dependent natural killer cell-mediated cytotoxicity and organ allograft rejection［J］.Front Immunol，2016，7：585.
［14］ MORETTA A，BOTTINO C，VITALE M，et al.Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis［J］.Annu Rev Immunol，2001，19：197-223.
［15］ ROMO N，MAGRI G，MUNTASELL A，et al.Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization［J］.J Leukoc Biol，2011，90（4）：717-726.
［16］ LUNDQVIST A，KREMER V.Markers and function of human NK cells in normal and pathological conditions［J］.Cytometry B Clin Cytom，2017，92（2）：98-99.
［17］ TSENG H C，CACALANO N，JEWETT A.Split anergized natural killer cells halt inflammation by inducing stem cell differentiation，resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion［J］.Oncotarget，2015，6（11）：8947-8959.
［18］ QIN Z，CHEN J，ZENG J，et al.Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma：a preliminary clinical study［J］.Cancer Biol Ther，2017，18（5）：323-330.
［19］ TAHTINEN S，KAIKKONEN S，MERISALO-SOIKKELI M，et al.Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors［J］.PLoS One，2015，10（6）：e0131242.
［20］ SHI J，ZHAO J，ZHANG X，et al.Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients［J］.Sci Rep，2017，7：44544.
［21］ GABRILOVICH D I，NAGARAJ S.Myeloid-derived suppressor cells as regulators of the immune system［J］.Nat Rev Immunol，2009，9（3）：162-174.
［22］ ACHYUT B R，SHANKAR A，ISKANDER A S，et al.Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks［J］.Cancer Lett，2015，369（2）：416-426.
［23］ SIEMENS D R，HU N，SHEIKHI A K，et al.Hypoxia increases tumor cell shedding of MHC class I chain-related molecule：role of nitric oxide［J］.Cancer Res，2008，68（12）：4746-4753.
［24］ CHEN Y，LIU W，WANG Y，et al.Casein kinase 2 interacting protein-1 regulates M1 and M2 inflammatory macrophage polarization［J］.Cell Signal，2017，33：107-121.
［25］ LI H，HAN Y，GUO Q，et al.Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1［J］.J Immunol，2009，182（1）：240-249.
［26］ WEI J，BARR J，KONG L Y，et al.Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway［J］.Mol Cancer Ther，2010，9（1）：67-78.
［27］ FELLERHOFF-LOSCH B，KOROL S V，GANOR Y，et al.Normal human CD4+ helper T cells express Kv1.1 voltage-gated K+ channels，and selective Kv1.1 block in T cells induces by itself robust TNFalpha production and secretion and activation of the NFkappaB non-canonical pathway［J］.J Neural Transm，2016，123（3）：137-157.
［28］ CHANMEE T，ONTONG P，KONNO K，et al.Tumor-associated macrophages as major players in the tumor microenvironment［J］.Cancers，2014，6（3）：1670-1690.
［29］ TERME M，CHAPUT N，COMBADIERE B，et al.Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells［J］.J Immunol，2008，180（7）：4679-4686.
相似文献/References:
[1]韩 伟,崔泰震,黄 健,等.胸腺肽联合抗结核药物治疗耐多药肺结核的临床疗效[J].新乡医学院学报,2015,32(12):1106.
[2]王国征,吴远彬,郭坤元,等.CD34CD38KG1a白血病干细胞对同种异体自然杀伤细胞的抵抗作用及其机制[J].新乡医学院学报,2019,36(9):828.[doi:10.7683/xxyxyxb.2019.09.006]
WANG Guo-zheng,WU Yuan-bin,GUO Kun-yuan,et al.Resistance of CD34CD38KG1a leukemic stem cells to allogeneic nature killer cells and its mechanism[J].Journal of Xinxiang Medical University,2019,36(11):828.[doi:10.7683/xxyxyxb.2019.09.006]
[3]王向鹏,左百乐,王冠玉,等.嵌合抗原受体修饰T细胞治疗实体肿瘤的研究现状[J].新乡医学院学报,2019,36(2):101.[doi:10.7683/xxyxyxb.2019.02.001]
[4]黄玉斌,刘 霄,徐翠香,等.胃癌干细胞和免疫检查点抑制剂治疗胃癌研究进展[J].新乡医学院学报,2022,39(5):486.[doi:10.7683/xxyxyxb.2022.05.017]
HUANG Yubin,LIU Xiao,XU Cuixiang,et al.Research progress of gastric cancer stem cells and immune checkpoint inhibitors therapy for gastric cancer[J].Journal of Xinxiang Medical University,2022,39(11):486.[doi:10.7683/xxyxyxb.2022.05.017]
[5]张静,张敏,路平.口腔鳞状细胞癌治疗研究进展[J].新乡医学院学报,2024,(2):180.[doi:10.7683/xxyxyxb.2024.02.014]
ZHANG Jing,ZHANG Min,LU Ping.Research progress in the treatment of oral squamous cell carcinoma[J].Journal of Xinxiang Medical University,2024,(11):180.[doi:10.7683/xxyxyxb.2024.02.014]